ACE and Hypertension: Overall, 25% were receiving beta-blockers, mostly for palpitation or chest pain, and 22% were receiving angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), primarily for hypertension.